TMS + Language Therapy for Aphasia
(TMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether combining Transcranial Magnetic Stimulation (TMS) with Speech-Language Therapy (SLT) can improve speech and understanding in people with mild aphasia, a language disorder caused by a stroke. Researchers aim to determine if this combination is more effective than a placebo version of TMS, which mimics TMS but has no real effect. The trial seeks participants who had a stroke on the left side of their brain over six months ago, have mild aphasia, and can speak English. Participants will undergo 10 treatment sessions and follow-up assessments to evaluate progress. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important early findings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Transcranial Magnetic Stimulation combined with Speech-Language Therapy is safe for treating mild aphasia?
Research has shown that Transcranial Magnetic Stimulation (TMS) is generally safe for people. Studies have found that most patients tolerate TMS well when treating conditions like post-stroke aphasia, which involves difficulty with language after a stroke. One study found that TMS safely improved speech, particularly in understanding spoken words.
Another study demonstrated that TMS, when combined with intensive therapy, remained safe and practical, even during longer sessions. Common side effects include mild headaches or discomfort at the stimulation site, but serious side effects are rare.
Since TMS is already used for other conditions, such as depression, this further suggests its safety. Overall, TMS appears promising as a safe method for aiding language recovery after a stroke.12345Why do researchers think this study treatment might be promising for aphasia?
Researchers are excited about using Transcranial Magnetic Stimulation (TMS) for treating aphasia because it offers a non-invasive approach that directly targets brain activity. Unlike traditional speech therapy, which primarily focuses on exercises to improve language skills, TMS uses magnetic fields to stimulate nerve cells in the brain regions responsible for language. This method has the potential to enhance the effectiveness of speech-language therapy by directly influencing brain function, potentially leading to faster and more significant improvements in language abilities.
What evidence suggests that TMS combined with SLT might be an effective treatment for mild aphasia?
In this trial, participants will be randomized into two groups to evaluate the effectiveness of Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) for aphasia. Research has shown that using TMS along with SLT can aid individuals with aphasia, a language problem caused by brain damage. For those who experienced a stroke at least six months ago, TMS significantly improved language skills. One study found that TMS had both immediate and long-lasting positive effects on language recovery. Another study showed that low-frequency TMS, when used with SLT, improved language abilities in stroke patients with long-term aphasia. These findings suggest that TMS, combined with SLT, could effectively enhance speech and understanding in people with mild aphasia after a stroke.23678
Who Is on the Research Team?
H. Branch Coslett, MD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for individuals with mild aphasia due to chronic stroke. Participants must complete a medical screening, be eligible based on their MRI results, and commit to 10 consecutive sessions of treatment along with follow-up assessments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo a battery of tests to define their language function and a research MRI scan
Treatment
Participants receive 10 consecutive sessions of TMS and SLT treatment over 2 weeks
Follow-up
Participants complete follow-up assessments to monitor language functioning
What Are the Treatments Tested in This Trial?
Interventions
- Speech-Language Therapy
- Transcranial Magnetic Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Temple University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator